Acetic Anhydride → 3-(1-acetylpiperidin-4-yl)-3-(4-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidin-5-yl)-1H-pyrazol-1-yl)propanenitrile
反応式
Cl.[CH3:2][N:3]1[CH:7]=[C:6]([C:8]2[N:13]=[C:12]([C:14]3[CH:15]=[N:16][N:17]([CH:19]([CH:23]4[CH2:28][CH2:27][NH:26][CH2:25][CH2:24]4)[CH2:20][C:21]#[N:22])[CH:18]=3)[N:11]3[CH:29]=[CH:30][N:31]=[C:10]3[CH:9]=2)[CH:5]=[N:4]1.C1C[O:35][CH2:34][CH2:33]1.C(N(CC)CC)C.C(OC(=O)C)(=O)C>C(=O)(O)[O-].[Na+].CCOC(C)=O>[C:34]([N:26]1[CH2:27][CH2:28][CH:23]([CH:19]([N:17]2[CH:18]=[C:14]([C:12]3[N:11]4[CH:29]=[CH:30][N:31]=[C:10]4[CH:9]=[C:8]([C:6]4[CH:5]=[N:4][N:3]([CH3:2])[CH:7]=4)[N:13]=3)[CH:15]=[N:16]2)[CH2:20][C:21]#[N:22])[CH2:24][CH2:25]1)(=[O:35])[CH3:33]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 2
実験手順
3-(4-(7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-c]pyrimidin-5-yl)-1H-pyrazol-1-yl)-3-(piperidin-4-yl)propanenitrile hydrochloride (10.0 mg, 0.021 mmol) was suspended in THF (211 μL, 0.0211 mmol). To this was added triethylamine (8.81 DIPHOS, 0.0632 mmol) to free-base. Acetic anhydride (2.38 μL, 0.0253 mmol) was added and the reaction mixture stirred at ambient temperature for 30 minutes. The reaction mixture was then diluted in saturated sodium bicarbonate and EtOAc. The layers were separated and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with brine, dried with MgSO4, filtered and concentrated in vacuo. Purification of the resulting crude material by reverse phase HPLC using 0-100% acetonitrile/water gradient afforded the title compound (7.2 mg, 77% yield). MS (apci) m/z=444.3 (M+H).
後処理
- customThe layers were separated
- extractionthe aqueous layer was extracted with EtOAc
- washThe combined organic layers were washed with brine
- dry with materialdried with MgSO4
- filtrationfiltered
- concentrationconcentrated in vacuo
- customPurification of the resulting crude material by reverse phase
出典と根拠
- ORDレコード
- ord-a0dcd2ed781343f2a08236443c88c884
- 出典データセット
- uspto-grants-2015_02
- 特許番号
- US08962596B2
反応ノート
読み込み中…